Mediphage's Proprietary msDNA Platform Technology

+Multiple Transgene Options

Ministring DNA (msDNA^TM) is a linear covalently closed (LCC), backbone-free DNA minivector that is produced in an established and scalable 1-step E.coli fermentation manufacturing process, which allows it to maintain a high degree of fidelity.

msDNA’s properties allow it to provide enhancements for a variety of applications:

For viral gene therapies, (i.e. rAAV, lentiviruses), mRNA therapeutics, vaccines, and gene addition.
Description text goes here
Description text goes here

msDNA ^TM is a superior DNA vector

Collaborations and Pipeline
Advancing the platform with potential licensing opportunities to derisk growth

Mediphage is actively seeking partners interested in evaluating ministring DNA through a joint feasibility study which can lead to the use of ministring DNA as part of a therapeutic solution. Specifically, within gene or cell therapy and gene editing categories, we are interested in plasmids for viral production. If you are interested in partnering with us, we want to hear from you.

Partnership Opportunities *